WORK Medical Technology (WOK) Operating Leases (2023 - 2025)

WORK Medical Technology (WOK) posted Operating Leases of $18756.0 for Q3 2025, up 9.01% on a QoQ basis from $17205.0 in Q1 2025.

WORK Medical Technology (WOK) Operating Leases (2023 - 2025) Analysis & Trends

WORK Medical Technology's Operating Leases history runs 2 years deep, the most recent figure standing at $18756.0 for Q3 2025.

Quarterly Operating Leases changed N/A year-over-year to $18756.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $18756.0 (changed N/A YoY) and the FY2025 annual result came in at $18756.0, changed N/A from the prior year.
Operating Leases was $18756.0 for Q3 2025 at WORK Medical Technology, up from $17205.0 in the prior quarter.
Across five years, Operating Leases topped out at $50130.0 in Q3 2023 and bottomed at $17205.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-
10	WORK Medical Technology	544,886.04	3.37 Mn	-

Download Data